A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Patients with hepatocellular carcinoma and esophageal varices bleeding were randomized to
undergo endoscopic ligation alone (group A) and additive propranolol treatment (group B)
after stabilization of their first acute bleeding.